Colgate-Palmolive's first quarter results were shaped by weaker consumer demand and category softness across key markets, ...

0.38 = US$4.3b ÷ (US$17b - US$5.6b) (Based on the trailing twelve months to September 2024). Thus, Colgate-Palmolive has an ROCE of 38%. In absolute terms that's a great return and it's even ...

Colgate-Palmolive's Hill’s Pet Nutrition segment is a key growth driver, benefiting from rising pet ownership. See why CL stock is a Strong Buy.

Toothpaste and toothbrush giant Colgate-Palmolive hit a full-year revenue milestone in 2024 Last Updated: Jan. 31, 2025 at 10:29 a.m. ET First Published: Jan. 31, 2025 at 7:36 a.m. ET Share ...

Consumer products company Colgate-Palmolive (NYSE:CL) will be reporting earnings tomorrow before the bell. Here’s what to look for. Colgate-Palmolive beat analysts’ revenue expectations by 1.1 ...

Colgate-Palmolive's Valuation Appears Fair. Data by YCharts. Relative to peers, Colgate-Palmolive has a decent valuation of 25.6x price-to-earnings, which is inferior to Clorox and Church & Dwight ...

Colgate-Palmolive now sees 2023 sales up 2% to 5% and 2023 EPS up in low to mid-single digits. Despite the top and bottom line beat, Colgate-Palmolive’s stock fell 3.2% before market open.

Colgate-Palmolive's product prices rose 4.2% in the second quarter. Its organic volumes jumped 4.7%, after having dipped 3% in the year-ago quarter.

Colgate-Palmolive shares fell 0.2% to trade at $86.57 on Monday. Pre-IPO Offer: Get A Piece Of A Nearly $5T Global Opportunity By Joining BOXABL As An Early Shareholder At Just $0.80/Share.

Colgate-Palmolive Co. shares are down 4.9% Friday despite the toothpaste and toothbrush giant reporting better-than-expected fourth-quarter profit and hitting a full-year revenue milestone.